http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MD-3645-G2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3cfe6833a0d8d297b5f9f81638f9755
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4350423c80713d64cfa43aee72043370
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_415dd26cf1d3aeb12c73c0b5c0229250
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2abca0b7d880e166849de5c5c6f80945
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a10cb573fce046c118abe79a51c83033
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0f8efb9544b56c16fffc496571854d0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c766a82fe0f752bf27d91663ec8aeefa
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155
filingDate 2008-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba1f6149662034b608a321133614bd50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_601b1267631ce2fb391ad07fd825bd14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d866341d97c8ea434fb576316d2d6a26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41b30d1f577941175b443c8499c2cf36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cff33a8a67282efb4c887604f3b051c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0d7540b4f229a9875a258a65ba3435b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b53cac84ed507e8cab57634b7864f415
publicationDate 2009-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MD-3645-G2
titleOfInvention Method for the treatment of uterine hypotonic postpartum hemorrhage
abstract The invention relates to medicine, namely to obstetrics and can be used to treat uterine hypotonic postpartum hemorrhage. The essence of the invention lies in the fact that the drug containing prostaglandins Misoprostol 400 μg per rectum is administered, and in addition, a solution containing 0.02 g of S-ethylisothiouronium bromide diluted in physiological saline.
priorityDate 2008-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MD-2323-G2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1616673-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590652
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452831597
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282381
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID200213

Total number of triples: 31.